Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances.
Coumarin compounds are emerging as candidates for enzyme-targeted therapies, opening new possibilities for more precise drug design.
This PubMed record reports: As the biochemical understanding of coumarins deepens, their role in precision medicine and enzyme-targeted therapies is poised to expand, unlocking new possibilities in disease treatment and drug design. The finding is retained for rapid triage and requires downstream evidence review before clinical interpretation.
What the study was
- Study design
- Systematic review
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Indian journal of clinical biochemistry : IJCB
Why it surfaced
Retained because its systematic review evidence is relevant to Precision oncology and genomic medicine; scoring is conservative for the available metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.